Sage Rhino Capital LLC Vincerx Pharma, Inc. Transaction History
Sage Rhino Capital LLC
- $439 Million
- Q3 2024
A detailed history of Sage Rhino Capital LLC transactions in Vincerx Pharma, Inc. stock. As of the latest transaction made, Sage Rhino Capital LLC holds 1,703,413 shares of VINC stock, worth $323,648. This represents 0.28% of its overall portfolio holdings.
Number of Shares
1,703,413
Previous 1,703,413
-0.0%
Holding current value
$323,648
Previous $1.38 Million
11.09%
% of portfolio
0.28%
Previous 0.34%
Shares
4 transactions
Others Institutions Holding VINC
# of Institutions
28Shares Held
11MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY2.7MShares$513,7600.03% of portfolio
-
Prosight Management, LP Dallas, TX2.21MShares$419,2350.43% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD892KShares$169,4260.02% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct674KShares$128,0960.0% of portfolio
-
Goldman Sachs Group Inc New York, NY631KShares$119,9700.0% of portfolio
About Vincerx Pharma, Inc.
- Ticker VINC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,189,800
- Market Cap $4.03M
- Description
- Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...